Current knowledge of and attitudes toward human papillomavirus‐related disease prevention among Japanese: A large‐scale questionnaire study

The human papillomavirus (HPV) vaccination rate in Japan fell to nearly 0% following widespread coverage of possible adverse events. Developing a next approach to promote the effective prevention of HPV‐related diseases including cervical cancer (CC) in Japan requires comprehensive understanding of knowledge and attitudes regarding CC prevention, HPV infection and HPV vaccination among the population including laypersons and medical professions in Japan.

[1]  B. Corcoran,et al.  Rapid response to HPV vaccination crisis in Ireland , 2018, The Lancet.

[2]  Sadao Suzuki,et al.  No association between HPV vaccine and reported post-vaccination symptoms in Japanese young women: Results of the Nagoya study , 2018, Papillomavirus research.

[3]  B. Jeong,et al.  Awareness of and Attitudes toward Human Papillomavirus Vaccination among Adults in Korea: 9-Year Changes in Nationwide Surveys , 2017, Cancer research and treatment : official journal of Korean Cancer Association.

[4]  L. Foxhall,et al.  American Society of Clinical Oncology Statement: Human Papillomavirus Vaccination for Cancer Prevention. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  F. Bray,et al.  Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis. , 2016, The Lancet. Global health.

[6]  F. Napolitano,et al.  Human papillomavirus infection and vaccination: Knowledge and attitudes among young males in Italy , 2016, Human vaccines & immunotherapeutics.

[7]  A. Crispin,et al.  HPV vaccination: acceptance and influencing factors among young men in Germany. , 2016, Future microbiology.

[8]  I. Tsuji,et al.  Awareness and health consciousness regarding the national health plan "Health Japan 21" (2nd edition) among the Japanese population in 2013 and 2014. , 2016, [Nihon koshu eisei zasshi] Japanese journal of public health.

[9]  M. Sekine,et al.  Survey of Japanese mothers of daughters eligible for human papillomavirus vaccination on attitudes about media reports of adverse events and the suspension of governmental recommendation for vaccination , 2015, The journal of obstetrics and gynaecology research.

[10]  K. Katanoda,et al.  Cancer incidence and incidence rates in Japan in 2009: a study of 32 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. , 2015, Japanese journal of clinical oncology.

[11]  Gitte Lee Mortensen,et al.  Parental attitudes towards male human papillomavirus vaccination: a pan-European cross-sectional survey , 2015, BMC Public Health.

[12]  Elizabeth R. Unger,et al.  Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices , 2015, MMWR. Morbidity and mortality weekly report.

[13]  M. Sekine,et al.  Japan's failure to vaccinate girls against human papillomavirus. , 2015, American journal of obstetrics and gynecology.

[14]  E. Miyagi,et al.  Three‐year questionnaire survey on human papillomavirus vaccination targeting new female college students , 2015, The journal of obstetrics and gynaecology research.

[15]  S. Garland,et al.  Web-based Recruiting for a Survey on Knowledge and Awareness of Cervical Cancer Prevention Among Young Women Living in Kanagawa Prefecture, Japan , 2014, International Journal of Gynecologic Cancer.

[16]  E. Miyagi,et al.  Attitudes toward cervical cancer screening among women receiving human papillomavirus vaccination in a university‐hospital‐based community: Interim 2‐year follow‐up results , 2014, The journal of obstetrics and gynaecology research.

[17]  N. Sakuragi,et al.  Acceptance of and attitudes towards human papillomavirus vaccination in Japanese mothers of adolescent girls. , 2012, Vaccine.

[18]  Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011. , 2011, MMWR. Morbidity and mortality weekly report.

[19]  D. Lowy,et al.  Human papillomavirus infection and the primary and secondary prevention of cervical cancer , 2008, Cancer.

[20]  June A. Flora,et al.  Social Marketing and Public Health Intervention , 1988, Health education quarterly.

[21]  J. Prochaska,et al.  Self-Change Processes, Self-Efficacy and Self-Concept in Relapse and Maintenance of Cessation of Smoking , 1982, Psychological reports.